Pfizer announced Thursday that a third shot of its COVID-19 vaccine raised omicron-fighting antibody by 36 times in children ages 5 to 11. Pfizer/BioNTech plans to request emergency use authorization ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
(NEXSTAR) – News is developing so quickly when it comes to COVID-19 booster shots, it can be hard to keep track of what’s happening. Have they been approved? Am I eligible? When can I get one? The ...
Americans could soon see a major increase in access to COVID-19 vaccine booster shots. On Friday, the U.S. Food and Drug Administration (FDA) announced its Vaccines and Related Biological Products ...
PHILADELPHIA (WPVI) -- The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five ...
WASHINGTON - A panel of advisers to the U.S. Centers for Disease Control and Prevention on Thursday continued discussing specific recommendations about who should get Pfizer’s COVID-19 booster shot — ...
WASHINGTON -- The Food and Drug Administration on Monday authorized booster shots of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds, part of an effort to expand protection as schools, ...
The Pfizer/BioNTech Covid-19 vaccine booster plan remains on track for the week of September 20, according to a source familiar with the discussion, but it may take a few weeks longer to move forward ...
NEW YORK, Aug 13 (Reuters) - Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results